CSIR Central

Cell-penetrating peptide and antibiotic combination therapy: a potential alternative to combat drug resistance in methicillin-resistant Staphylococcus aureus.

IR@IMTECH: CSIR-Institute of Microbial Technology, Chandigarh

View Archive Info
 
 
Field Value
 
Title Cell-penetrating peptide and antibiotic combination therapy: a potential alternative to combat drug resistance in methicillin-resistant Staphylococcus aureus.
 
Creator Randhawa, Harmandeep Kaur
Gautam, Ankur
Sharma, Minakshi
Bhatia, Rakesh
Varshney, Grish C
Raghava, G.P.S.
Nandanwar, Hemraj
 
Subject QR Microbiology
 
Description The diverse pattern of resistance by methicillin-resistant Staphylococcus aureus (MRSA) is the major obstacle in the treatment of its infections. The key reason of resistance is the poor membrane permeability of drug molecules. Over the last decade, cell-penetrating peptides (CPPs) have emerged as efficient drug delivery vehicles and have been exploited to improve the intracellular delivery of numerous therapeutic molecules in preclinical studies. Therefore, to overcome the drug resistance, we have investigated for the first time the effects of two CPPs (P3 and P8) in combination with four antibiotics (viz. oxacillin, erythromycin, norfloxacin, and vancomycin) against MRSA strains. We found that both CPPs internalized into the MRSA efficiently at very low concentration (<10 μM) which was non-toxic to bacteria as well as mammalian cells and showed no significant hemolytic activity. However, the combinations of CPPs (≤10 μM) and antibiotics showed high toxicity against MRSA as compared to antibiotics alone. The significant finding is that P3 and P8 could lower the MICs against oxacillin, norfloxacin, and vancomycin to susceptible levels (generally <1 μg/mL) for almost all five clinical isolates. Further, the bacterial cell death was confirmed by scanning electron microscopy as well as propidium iodide uptake assay. Simultaneously, time-kill kinetics revealed the increased uptake of antibiotics. In summary, CPPs assist to restore the effectiveness of antibiotics at much lower concentration, eliminate the antibiotic toxicity, and represent the CPP-antibiotic combination therapy as a potential novel weapon to combat MRSA infections.
 
Publisher Springer
 
Date 2016-03
 
Type Article
PeerReviewed
 
Relation http://link.springer.com/article/10.1007%2Fs00253-016-7329-7
http://crdd.osdd.net/open/1834/
 
Identifier Randhawa, Harmandeep Kaur and Gautam, Ankur and Sharma, Minakshi and Bhatia, Rakesh and Varshney, Grish C and Raghava, G.P.S. and Nandanwar, Hemraj (2016) Cell-penetrating peptide and antibiotic combination therapy: a potential alternative to combat drug resistance in methicillin-resistant Staphylococcus aureus. Applied microbiology and biotechnology, 100 (9). pp. 4073-4083. ISSN 1432-0614